Answers are grounded in this paper and cite their sources.
Akinetic crisis (AC) in Parkinson's disease (PD) is a life-threatening complication precipitated by abrupt changes or the impaired absorption of dopaminergic medication. We report a case of AC precipitated by an unintended suspension of continuous subcutaneous foslevodopa-foscarbidopa infusion (CSFLI) in a patient with advanced PD in a perioperative setting. Our observations highlight that despite its reputation as a reliable device-aided therapy (DAT), CSFLI remains vulnerable to abrupt interruptions and it may entail an under-recognized risk of AC. This case underscores the need for alternative dopaminergic routes, careful perioperative planning, and multidisciplinary collaboration in managing patients with advanced PD undergoing DAT.
No takes yet. Share an insight, caveat, or question.
Kobayashi et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: